Each 1 ml of vaccine contains:
Active substances:
C. perfringens type A toxoid | ≥ 0.9 U3 | |
C. perfringens type B & C (β) toxoid | ≥ 12.4 U1 | |
C. perfringens type D (ε) toxoid | ≥ 5.1 U1 | |
C. chauvoei whole culture, inactivated | meets Ph. Eur.2 | |
C. novyi toxoid | ≥ 1.2 U1 | |
C. septicum toxoid | ≥ 3.6 U1 | |
C. tetani toxoid | ≥ 2.5 U1 | |
C. sordellii toxoid | ≥ 0.8 U1 | |
C. haemolyticum toxoid | ≥ 16.5 U3 | |
1 In-house ELISA
2 Challenge test according to Ph. Eur.
3 In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes.
Adjuvant:
Alum | 3.03 – 4.09 mg Aluminium | |
Excipients:
Qualitative composition of excipients and other constituents | Quantitative composition if that information is essential for proper administration of the veterinary medicinal product |
Thiomersal | 0.05 – 0.18 mg |
Formaldehyde | |
Sodium Chloride | |
Water for injections | |
Light brown aqueous suspension that settles on storage.